Wyeth Pharmaceuticals
- All
- News
-
Pfizer Announces Completion of Merger With Wyeth
Drug major Pfizer on Monday announced completion of its merger with Wyeth Ltd, thereby placing itself among the top ten pharmaceutical companies in India by market share.
-
US Prosecutors Seek 8-Year Sentence for Indian-Origin Fund Manager Martoma
An Indian-origin portfolio manager, convicted for his role as the "central figure" in one of the most lucrative insider trading schemes in US history, should be sentenced to more than eight years in prison, Manhattan's top federal prosecutor Preet Bharara has said.
-
Sun Pharma to pay Rs 2,517 crore to settle patent suit
Drug maker Sun Pharmaceutical Industries has said it will pay its dues of Rs 2,517.41 crore soon as part of settlement agreement with Wyeth (now a division of Pfizer Inc) and Altana Pharma AG (now known as Takeda GmbH).
-
Sun Pharma shares fall on patent claims worth $960 million
US-based Wyeth Pharma has sought damages related to the ongoing patent dispute over Protonix.
-
Wyeth makes $960 mn claims on Protonix patent case: Sun Pharma
Sun Pharmaceutical Industries said that US-based Wyeth Pharmaceuticals has sought damages worth $960 million related to their ongoing patent dispute over a generic version of Protonix drug.
-
Pfizer Announces Completion of Merger With Wyeth
Drug major Pfizer on Monday announced completion of its merger with Wyeth Ltd, thereby placing itself among the top ten pharmaceutical companies in India by market share.
-
US Prosecutors Seek 8-Year Sentence for Indian-Origin Fund Manager Martoma
An Indian-origin portfolio manager, convicted for his role as the "central figure" in one of the most lucrative insider trading schemes in US history, should be sentenced to more than eight years in prison, Manhattan's top federal prosecutor Preet Bharara has said.
-
Sun Pharma to pay Rs 2,517 crore to settle patent suit
Drug maker Sun Pharmaceutical Industries has said it will pay its dues of Rs 2,517.41 crore soon as part of settlement agreement with Wyeth (now a division of Pfizer Inc) and Altana Pharma AG (now known as Takeda GmbH).
-
Sun Pharma shares fall on patent claims worth $960 million
US-based Wyeth Pharma has sought damages related to the ongoing patent dispute over Protonix.
-
Wyeth makes $960 mn claims on Protonix patent case: Sun Pharma
Sun Pharmaceutical Industries said that US-based Wyeth Pharmaceuticals has sought damages worth $960 million related to their ongoing patent dispute over a generic version of Protonix drug.
